FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 3053286 · Received April 11, 2013

Report

Report Number
2124215-2013-04754
Event Type
Injury
Date Received
April 11, 2013
Date of Event
March 20, 2013
Report Date
March 26, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION PROVIDED NOTED THAT THIS LEAD WAS REPOSITIONED SUCCESSFULLY.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A FOLLOW UP HIGH THRESHOLDS RESULTING IN LOSS OF CAPTURE WAS NOTED. A REPOSITIONING PROCEDURE HAS BEEN SCHEDULED FOR THIS DISLODGED RIGHT ATRIAL LEAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
155538 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4096

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening| R